Innovative technologies like array comparative genomic hybridization (arrayCGH), single nucleotide polymorphism (SNP) arrays and next-generation sequencing revealed recurrent mutations of genes implicated in epigenetic control such as ASXL1, EZH2, DNMT3A and TET2 in MDS and AML. Here, TET2 is linked to myelodysplastic syndrome.